SEC Form 4 · accession 0001209191-19-017812
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff L Vacirca
Director
Period of report
Mar 4, 2019
Accepted (ET)
Mar 7, 2019 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2019 | P | 2,000 | $16.9999 | A | 3,000 | D | |
| Common Stock | Mar 4, 2019 | P | 1,000 | $17.00 | A | 4,000 | D |
Table II — derivative securities
No Table II lines on this filing.